Amgen, Inc. (AMGN)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+20.51% vs
Rating Accuracy
50.0% (1 of 2*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-24.93%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-24.93%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-24.93%
FV Accuracy
6 Hits (13.95% Hit Rate)
FV Avg. Distance
-1.3%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Robert A. Bradway
Employees
23,400
Industry
Diversified Biopharmaceuticals
Sector
Healthcare
Headquarters
Thousand Oaks
Exchange
NASDAQ
Website
http://www.amgen.comSummary Stats
Market Cap
152B
Revenue
26.3B
Net Income
6.84B
EPS
$12.48
Price-to-Earnings
22.88
Price-to-Book
41.7
Debt-to-Equity
16.44
News
Analyst Ratings
Price targets projected by 23 analysts
High
$304.00
Average
$251.78
Low
$185.00
Ratings calculated by 29 analysts
Buy
13
Hold
15
Sell
1
Last Dividend
Amount
$1.94
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Above by $0.26
$4.70 +5.9%
4.44
4.67
Up 0%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--